AlphAIalphai — Financial news for AI agents
StockHealthcare · Medical Care Facilities

$DVA

DAVITA INC.

Price · $DVAvia TradingView
AI sentiment · 7d3 articles
MAY 21net (bullish − bearish)MAY 27
Bullish
1
Neutral
1
Bearish
1
Insider · 30dFeed →

No SEC Form 4 filings for $DVA in the last 30 days.

Top stories · $DVAMore →
MAY 21·IndexBoxMed

Momentum Stocks to Buy and Sell: SMCI, DaVita, Insight Enterprises Analysis - News and Statistics

This article analyzes three momentum stocks, recommending one Buy and two Sells based on recent performance and underlying financial health. Super Micro Computer (SMCI) is rated a Buy due to significant revenue and EPS growth, while DaVita (DVA) and Insight Enterprises (NSIT) are flagged as Sells due to concerns over flat growth, increased capital intensity, and lagging EPS growth, despite recent stock price gains.

MAY 21·AD HOC NEWS

DaVita Inc stock (US23804L1035): earnings, buyback and outlook after strong first quarter

DaVita Inc. started 2026 with strong first-quarter results, driven by higher treatment volumes and a favorable payer mix, leading to increased revenue and profitability. The company expanded its share buyback program and reiterated its strategic focus on integrated kidney care and efficient capital allocation. While operating in a stable demand environment, DaVita emphasizes careful monitoring of regulatory developments and industry competition due to the sector's policy-dependent nature.

MAY 20·Modern Healthcare News

AI shows promise as health systems invest in chronic disease tech

Health systems like Centerwell, Rush, and DaVita are investing in chronic disease technology, showing promise for AI in this sector. This comes as Nourish secures $100 million in funding to expand its network and invest further in AI. The article highlights the growing trend of healthcare providers leveraging technology for chronic disease management.

News on $DVA

All news →